Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedDec 22, 2024
DataAggregated Company Financials
Companies7
  • 7D-1.8%
  • 3M-5.6%
  • 1Y26.8%
  • YTD29.1%

Over the last 7 days, the Life Sciences industry has dropped 1.8%, driven by a pullback from Bachem Holding of 12%. Over the past 12 months, the industry was up 27%. As for the next few years, earnings are expected to grow by 22% per annum.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 22 Dec 2024CHF 52.2bCHF 10.2bCHF 943.6m35.2x55.3x5.1x
Tue, 19 Nov 2024CHF 51.8bCHF 10.2bCHF 943.5m40.9x54.9x5.1x
Thu, 17 Oct 2024CHF 54.4bCHF 10.2bCHF 943.4m41.3x57.7x5.3x
Sat, 14 Sep 2024CHF 57.5bCHF 10.2bCHF 937.0m44.5x61.3x5.6x
Mon, 12 Aug 2024CHF 57.4bCHF 10.2bCHF 924.0m45.2x62.2x5.6x
Wed, 10 Jul 2024CHF 54.0bCHF 10.3bCHF 1.0b46.6x53.9x5.3x
Fri, 07 Jun 2024CHF 53.6bCHF 10.3bCHF 1.0b43.9x53.5x5.2x
Sun, 05 May 2024CHF 54.4bCHF 10.3bCHF 1.0b43.4x54.3x5.3x
Tue, 02 Apr 2024CHF 58.5bCHF 10.3bCHF 1.0b47x58.3x5.7x
Thu, 29 Feb 2024CHF 50.6bCHF 10.2bCHF 982.4m46.9x51.6x5x
Sat, 27 Jan 2024CHF 46.5bCHF 10.2bCHF 1.0b42.3x45.6x4.6x
Mon, 25 Dec 2023CHF 41.8bCHF 9.8bCHF 1.5b32.4x28x4.3x
Wed, 22 Nov 2023CHF 41.3bCHF 9.8bCHF 1.5b29.5x27.7x4.2x
Fri, 20 Oct 2023CHF 39.1bCHF 9.8bCHF 1.5b27.2x26.2x4x
Sun, 17 Sep 2023CHF 52.6bCHF 9.8bCHF 1.5b35.4x35.3x5.4x
Tue, 15 Aug 2023CHF 53.2bCHF 9.8bCHF 1.5b35.5x34.4x5.4x
Thu, 13 Jul 2023CHF 55.6bCHF 9.7bCHF 1.6b37.2x34x5.7x
Sat, 10 Jun 2023CHF 58.7bCHF 9.7bCHF 1.6b37x35.9x6.1x
Mon, 08 May 2023CHF 62.0bCHF 9.7bCHF 1.6b41.3x38x6.4x
Wed, 05 Apr 2023CHF 57.6bCHF 9.7bCHF 1.7b41.7x34.5x5.9x
Fri, 03 Mar 2023CHF 58.7bCHF 9.6bCHF 1.7b34.3x35.3x6.1x
Sun, 29 Jan 2023CHF 56.2bCHF 9.6bCHF 1.6b32.4x34.4x5.9x
Tue, 27 Dec 2022CHF 49.9bCHF 9.2bCHF 1.3b37x37.5x5.4x
Thu, 24 Nov 2022CHF 54.1bCHF 9.2bCHF 1.3b40.5x40.7x5.9x
Sat, 22 Oct 2022CHF 51.5bCHF 9.2bCHF 1.3b40.2x38.7x5.6x
Mon, 19 Sep 2022CHF 50.2bCHF 9.2bCHF 1.3b39.5x38.8x5.5x
Wed, 17 Aug 2022CHF 56.4bCHF 8.9bCHF 1.3b35.1x43x6.3x
Fri, 15 Jul 2022CHF 54.6bCHF 8.5bCHF 1.1b33.1x50.7x6.4x
Sun, 12 Jun 2022CHF 56.0bCHF 8.5bCHF 1.1b47.1x51.9x6.6x
Tue, 10 May 2022CHF 53.3bCHF 8.5bCHF 1.1b43.8x49.3x6.3x
Thu, 07 Apr 2022CHF 70.4bCHF 8.3bCHF 1.1b53.2x65.2x8.5x
Sat, 05 Mar 2022CHF 65.2bCHF 8.1bCHF 1.1b53.1x59.7x8x
Mon, 31 Jan 2022CHF 68.0bCHF 8.0bCHF 1.1b64.7x64.5x8.5x
Wed, 29 Dec 2021CHF 84.2bCHF 7.4bCHF 929.1m97.3x90.7x11.4x
Price to Earnings Ratio

90.7x


Total Market Cap: CHF 84.2bTotal Earnings: CHF 929.1mTotal Revenue: CHF 7.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 46.5x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 55.3x which is higher than its 3-year average PE of 46.5x.
  • The 3-year average PS ratio of 5.9x is higher than the industry's current PS ratio of 5.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-2.31%
Healthcare-1.28%
Life Sciences-1.83%
Clinical Research and Equipment-1.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PPGN PolyPeptide GroupCHF 28.754.7%
+CHF 42.9m
66.8%PS3.1x
SKAN SKAN GroupCHF 75.202.6%
+CHF 42.7m
-7.5%PE52.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.